Generated by AI
AdaptHealth Corp. is a healthcare services company that provides home medical equipment, medical supplies, and related patient support services across the United States. The company focuses on care delivered outside the hospital through offerings in sleep health, respiratory health, diabetes health, and wellness at home. Its products and services include sleep therapy equipment, oxygen and ventilation systems, continuous glucose monitors, insulin pumps, and a broad range of durable medical equipment used in chronic and post-acute care. AdaptHealth works with Medicare, Medicaid, and commercial insurance patients, serving individuals who need recurring medical support in the home. The company plays an important role in the healthcare-at-home market by helping patients manage ongoing conditions with equipment, supplies, and service coordination tailored to home-based care.
Website555 East North Lane
Conshohocken, PA, 19428
United States
The latest articles about AHCO.
AdaptHealth has seen its share price move around in recent years, which puts a spotlight on a basic question for anyone looking at the stock today. Is the current valuation that the market is placing on AdaptHealth really supported by what the business is generating in sales. Over the past 5 years the stock has fallen 65.8%, so any decision today leans heavily on whether the underlying revenue base can carry the current market value. The business model relies on turning recurring equipment...
AdaptHealth reported third quarter 2026 sales of US$745.65 million and a net loss of US$153.99 million. The loss was driven in part by a US$184.75 million goodwill impairment. The company then slightly raised full year net revenue guidance to a range of US$2.88 billion to US$2.90 billion. The combination of a sizeable impairment and widened losses with a higher revenue outlook highlights how AdaptHealth is absorbing past balance sheet hits while still signaling confidence in ongoing demand...
AdaptHealth (AHCO) is back in focus after a packed early November. The business reported a large third quarter goodwill impairment, raised full year 2026 revenue guidance, and posted fresh quarterly results that reshaped the recent story. Recent trading suggests investors are reassessing AdaptHealth. The 30 day share price return of 27.39% and 90 day gain of 33.80% come after a year to date share price decline of 20.17% and a 1 year total shareholder return fall of 19.08%, as the goodwill...
Summary of Aug 11's posts. Generated by AI.
Summary of Apr 13's posts. Generated by AI.
Summary of May 9's posts. Generated by AI.
Summary of Aug 11's posts. Generated by AI.
Investors talking about AHCO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.